tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Mesoblast Secures Medicaid Coverage for Ryoncil, Expanding Access for Pediatric Patients
Company AnnouncementsMesoblast Secures Medicaid Coverage for Ryoncil, Expanding Access for Pediatric Patients
2d ago
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
PremiumThe Fly
Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil
3d ago
MESO
Mesoblast Launches Ryoncil® in U.S. for Pediatric SR-aGvHD
PremiumCompany Announcements
Mesoblast Launches Ryoncil® in U.S. for Pediatric SR-aGvHD
6d ago
Mesoblast’s Ryoncil Gains Comprehensive U.S. Drug Pricing Compendia Inclusion
PremiumCompany Announcements
Mesoblast’s Ryoncil Gains Comprehensive U.S. Drug Pricing Compendia Inclusion
19d ago
Mesoblast Unveils First FDA-Approved Stem Cell Therapy
PremiumCompany Announcements
Mesoblast Unveils First FDA-Approved Stem Cell Therapy
21d ago
Mesoblast Director Increases Stake with ADS Acquisition
PremiumCompany AnnouncementsMesoblast Director Increases Stake with ADS Acquisition
21d ago
Mesoblast CEO to Present at ISCT Virtual Town Hall on Groundbreaking Cell Therapy
Premium
Company Announcements
Mesoblast CEO to Present at ISCT Virtual Town Hall on Groundbreaking Cell Therapy
21d ago
Mesoblast added to S&P/ASX 200 index
Premium
The Fly
Mesoblast added to S&P/ASX 200 index
27d ago
MESO
Mesoblast Joins S&P/ASX 200 Index, Marking Growth Milestone
PremiumCompany Announcements
Mesoblast Joins S&P/ASX 200 Index, Marking Growth Milestone
28d ago
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
PremiumRatings
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
1M ago
MESO
Mesoblast Limited Joins S&P/ASX 200 Index
PremiumCompany Announcements
Mesoblast Limited Joins S&P/ASX 200 Index
1M ago
Mesoblast Reports Loss Amid FDA Approval Milestone
PremiumCompany Announcements
Mesoblast Reports Loss Amid FDA Approval Milestone
1M ago
Mesoblast Launches FDA-Approved Ryoncil® for Pediatric SR-aGvHD
PremiumCompany AnnouncementsMesoblast Launches FDA-Approved Ryoncil® for Pediatric SR-aGvHD
1M ago
Mesoblast Limited Reports Half-Year Financial Results and Operational Update
Premium
Company Announcements
Mesoblast Limited Reports Half-Year Financial Results and Operational Update
1M ago
Mesoblast Limited Files SEC Report for 2024
Premium
Company Announcements
Mesoblast Limited Files SEC Report for 2024
1M ago
Mesoblast Limited Announces New Director Appointment
PremiumCompany Announcements
Mesoblast Limited Announces New Director Appointment
1M ago
Mesoblast Appoints Dr. Gregory George to Board, Strengthening Operational Expertise
PremiumCompany Announcements
Mesoblast Appoints Dr. Gregory George to Board, Strengthening Operational Expertise
1M ago
Mesoblast’s Ryoncil® Gains FDA Approval, Set to Revolutionize SR-aGvHD Treatment
PremiumCompany Announcements
Mesoblast’s Ryoncil® Gains FDA Approval, Set to Revolutionize SR-aGvHD Treatment
2M ago
Mesoblast price target raised to $24 from $15 at Piper Sandler
PremiumThe Fly
Mesoblast price target raised to $24 from $15 at Piper Sandler
2M ago
MESO
Change in Substantial Holder Interests at Mesoblast Limited
PremiumCompany AnnouncementsChange in Substantial Holder Interests at Mesoblast Limited
2M ago
Mesoblast Launches Ryoncil® in U.S. for Pediatric Graft-Versus-Host Disease
Premium
Company Announcements
Mesoblast Launches Ryoncil® in U.S. for Pediatric Graft-Versus-Host Disease
2M ago
Mesoblast provides update on progress of U.S. commercial launch of Ryoncil
Premium
The Fly
Mesoblast provides update on progress of U.S. commercial launch of Ryoncil
2M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >